No reconstitution, syringes, or refrigeration needed
It is not approved for human or animal use, therapeutic protocols, or diagnostic procedures
Based on the phase 2 and phase 3 trial protocols: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Weeks 17 onward: 12 mg once weekly (maximum dose) The starting dose of retatrutide is deliberately low because the triple-agonist mechanism produces more intense initial side effects than single-pathway compounds
A single-cell atlas of the tumor and immune ecosystem of human breast cancer
In aged rodents, the same pharmacology has been extended to skeletal-muscle pathology, where it preserves muscle stem cell function and mitigates sarcopenia [3]
Radiant skin complexion Glutathione's skin-brightening, detoxifying, and antioxidant effects combine to create a radiant complexion